The DOI matches its Crossref record; 147 of the 147 references it cites were found in a registry or an index.
Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?
Abstract
The etiology of nerve cell death in neuronal degenerative diseases is unknown, but it has been hypothesized that excitotoxic mechanisms may play a role. Such mechanisms may play a role in diseases such as Huntington's disease, Parkinson's disease, amyotrophic lateral sclerosis, and Alzheimer's disease. In these illnesses, the slowly evolving neuronal death is unlikely to be due to a sudden release of glutamate, such as occurs in ischemia. One possibility, however, is that a defect in mitochondrial energy metabolism could secondarily lead to slow excitotoxic neuronal death, by making neurons more vulnerable to endogenous glutamate. With reduced oxidative metabolism and partial cell membrane depolarization, voltage‐dependent N‐methyl‐D‐apartate (NMDA) receptor ion channels would be more easily activated. In addition, several other processes involved in buffering intracellular calcium may be impaired. Recent studies in experimental animals showed that mitochondrial toxins can result in a pattern of neuronal degeneration closely resembling that seen in Huntington's disease, which can be blocked with NMDA antagonists. NMDA antagonists also block neuronal degeneration induced by 1‐methyl‐4‐phenylpyridium, which has been implicated in experimental models of Parkinson's disease. The delayed onset of neurodegenerative illnesses could be related to the progressive impairment of mitochondrial oxidative phosphorylation, which accompanies normal aging. If defective mitochondrial energy metabolism plays a role in cell death in neurodegenerative disorders, potential therapeutic strategies would be to use excitatory amino acid antagonists or agents to bypass bioenergetic defects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glutamate neurotoxicity and diseases of the nervous system
CHOI, D. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 7,972
Mitochondrial DNA mutation associated with Leber’s hereditary optic neuropathy
Wallace, D. C., Singh, G., Lott, M. T., Hodge, J. A., Schurr, T. G., Lezza, A. M. S., Elsas, L. J., & Nikoskelainen, E. K. (1988) · Science · doi:10.1126/science.3201231 · Cited by 2,440
Mitochondrial Complex I Deficiency in Parkinson's Disease
Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283
Goto, Y.-I., Nonaka, I., & Horai, S. (1990) · Nature · doi:10.1038/348651a0 · Cited by 2,070
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
Brain Lesions, Obesity, and Other Disturbances in Mice Treated with Monosodium Glutamate
Olney, J. W. (1969) · Science · doi:10.1126/science.164.3880.719 · Cited by 1,804
Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage
Choi, D. W. (1988) · Trends in Neurosciences · doi:10.1016/0166-2236(88)90200-7 · Cited by 1,736
Normal oxidative damage to mitochondrial and nuclear DNA is extensive.
Richter, C., Park, J. W., & Ames, B. N. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.17.6465 · Cited by 1,725
THE MITOCHONDRIAL ELECTRON TRANSPORT AND OXIDATIVE PHOSPHORYLATION SYSTEM
Hatefi, Y. (1985) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.54.070185.005055 · Cited by 1,680
Shoffner, J. M., Lott, M. T., Lezza, A. M. S., Seibel, P., Ballinger, S. W., & Wallace, D. C. (1990) · Cell · doi:10.1016/0092-8674(90)90059-n · Cited by 1,482
Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid
Beal, M. F., Kowall, N. W., Ellison, D. W., Mazurek, M. F., Swartz, K. J., & Martin, J. B. (1986) · Nature · doi:10.1038/321168a0 · Cited by 1,286
Self-citationQuinolinic Acid: An Endogenous Metabolite That Produces Axon-Sparing Lesions in Rat Brain
Schwarcz, R., Whetsell, W. O., & Mangano, R. M. (1983) · Science · doi:10.1126/science.6849138 · Cited by 1,263
Lesion of striatal neurons with kainic acid provides a model for Huntington's chorea
COYLE, J. T., & SCHWARCZ, R. (1976) · Nature · doi:10.1038/263244a0 · Cited by 1,248
Siesjö, B. K., & Bengtsson, F. (1989) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1989.20 · Cited by 1,231
Abnormalities of the electron transport chain in idiopathic parkinson's disease
Parker, W. D., Boyson, S. J., & Parks, J. K. (1989) · Annals of Neurology · doi:10.1002/ana.410260606 · Cited by 1,063
Pearson, R. C., Esiri, M. M., Hiorns, R. W., Wilcock, G. K., & Powell, T. P. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.13.4531 · Cited by 987
Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases
Linnane, A., Ozawa, T., Marzuki, S., & Tanaka, M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92145-4 · Cited by 983
Luft, R., Ikkos, D., Palmieri, G., Ernster, L., & Afzelius, B. (1962) · Journal of Clinical Investigation · doi:10.1172/jci104637 · Cited by 981
Novelli, A., Reilly, J. A., Lysko, P. G., & Henneberry, R. C. (1988) · Brain Research · doi:10.1016/0006-8993(88)90765-2 · Cited by 971
Guam Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Linked to a Plant Excitant Neurotoxin
Spencer, P. S., Nunn, P. B., Hugon, J., Ludolph, A. C., Ross, S. M., Roy, D. N., & Robertson, R. C. (1987) · Science · doi:10.1126/science.3603037 · Cited by 897
MCGEER, E. G., & MCGEER, P. L. (1976) · Nature · doi:10.1038/263517a0 · Cited by 834
Hartl, F.-U., Pfanner, N., Nicholson, D. W., & Neupert, W. (1989) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(89)90002-6 · Cited by 806
Selective Sparing of a Class of Striatal Neurons in Huntington's Disease
Ferrante, R. J., Kowall, N. W., Beal, M. F., Richardson, E. P., Bird, E. D., & Martin, J. B. (1985) · Science · doi:10.1126/science.2931802 · Cited by 757
Self-citationDeficiencies in Complex I subunits of the respiratory chain in Parkinson's disease
Mizuno, Y., Ohta, S., Tanaka, M., Takamiya, S., Suzuki, K., Sato, T., Oya, H., Ozawa, T., & Kagawa, Y. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)91141-8 · Cited by 739
Decline in skeletal muscle mitochondrial respiratory chain function: possible factor in ageing
Trounce, I., Byrne, E., & Marzuki, S. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92143-0 · Cited by 730
Schapira, A. H. V., Mann, V. M., Cooper, J. M., Dexter, D., Daniel, S. E., Jenner, P., Clark, J. B., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb05809.x · Cited by 673
Zeviani, M., Servidei, S., Gellera, C., Bertini, E., DiMauro, S., & DiDonato, S. (1989) · Nature · doi:10.1038/339309a0 · Cited by 637
Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis
Rothstein, J. D., Tsai, G., Kuncl, R. W., Clawson, L., Cornblath, D. R., Drachman, D. B., Pestronk, A., Stauch, B. L., & Coyle, J. T. (1990) · Annals of Neurology · doi:10.1002/ana.410280106 · Cited by 636
β-Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage
Koh, J.-Y., Yang, L. L., & Cotman, C. W. (1990) · Brain Research · doi:10.1016/0006-8993(90)91355-k · Cited by 617
Cytochrome oxidase deficiency in Alzheimer’s disease
Parker, W. D., Filley, C. M., & Parks, J. K. (1990) · Neurology · doi:10.1212/wnl.40.8.1302 · Cited by 598
Moraes, C. T., Shanske, S., Tritschler, H., Aprille, J. R., Andreetta, F., Bonilla, E., Schon, E. A., & DiMauro, S. (1991) · PubMed · Cited by 586
Positron emission tomography in Alzheimer's disease
Duara, R., Grady, C., Haxby, J., Sundaram, M., Cutler, N. R., Heston, L., Moore, A., Schlageter, N., Larson, S., & Rapoport, S. I. (1986) · Neurology · doi:10.1212/wnl.36.7.879 · Cited by 568
Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists
Turski, L., Bressler, K., Jürgen Rettig, K., Löschmann, P.-A., & Wachtel, H. (1991) · Nature · doi:10.1038/349414a0 · Cited by 546
An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P.
Kowall, N. W., Beal, M. F., Busciglio, J., Duffy, L. K., & Yankner, B. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.16.7247 · Cited by 522
Self-citationCalcium transport and buffering in neurons
Blaustein, M. P. (1988) · Trends in Neurosciences · doi:10.1016/0166-2236(88)90195-6 · Cited by 512
Chronic quinolinic acid lesions in rats closely resemble Huntington's disease
Beal, M., Ferrante, R., Swartz, K., & Kowall, N. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-06-01649.1991 · Cited by 499
Self-citationTonic Activation of NMDA Receptors by Ambient Glutamate Enhances Excitability of Neurons
Sah, P., Hestrin, S., & Nicoll, R. A. (1989) · Science · doi:10.1126/science.2573153 · Cited by 441
Fukuhara, N., Tokiguchi, S., Shirakawa, K., & Tsubaki, T. (1980) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(80)90031-3 · Cited by 425
PHOSPHORYLATION COUPLED TO OXIDATION OF DIHYDRODIPHOSPHOPYRIDINE NUCLEOTIDE
Lehninger, A. L. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)56077-4 · Cited by 420
Rogers, J., & Morrison, J. (1985) · The Journal of Neuroscience · doi:10.1523/jneurosci.05-10-02801.1985 · Cited by 410
Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain
Sorbi, S., Bird, E. D., & Blass, J. P. (1983) · Annals of Neurology · doi:10.1002/ana.410130116 · Cited by 396
NMDA Receptor Losses in Putamen from Patients with Huntington's Disease
Young, A. B., Greenamyre, J. T., Hollingsworth, Z., Albin, R., D'Amato, C., Shoulson, I., & Penney, J. B. (1988) · Science · doi:10.1126/science.2841762 · Cited by 395
Kuhl, D. E., Phelps, M. E., Markham, C. H., Metter, E. J., Riege, W. H., & Winter, J. (1982) · Annals of Neurology · doi:10.1002/ana.410120504 · Cited by 376
Kobayashi, Y., Momoi, M. Y., Tominaga, K., Momoi, T., Nihei, K., Yanagisawa, M., Kagawa, Y., & Ohta, S. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)80860-5 · Cited by 364
Increase of deleted mitochondrial DNA in the striatum in Parkinson's disease and senescence
Ikebe, S.-I., Tanaka, M., Ohno, K., Sato, W., Hattori, K., Kondo, T., Mizuno, Y., & Ozawa, T. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)90497-b · Cited by 341
Alterations in L-Glutamate Binding in Alzheimer's and Huntington's Diseases
Greenamyre, J. T., Penney, J. B., Young, A. B., D'Amato, C. J., Hicks, S. P., & Shoulson, I. (1985) · Science · doi:10.1126/science.2858129 · Cited by 333
Methods for antagonizing glutamate neurotoxicity.
Choi, D. W. (1990) · PubMed · Cited by 332
Michenfelder, J. D. (1976) · Archives of Neurology · doi:10.1001/archneur.1976.00500050031006 · Cited by 328
Reduced Cerebral Glucose Metabolism in Asymptomatic Subjects at Risk for Huntington's Disease
Mazziotta, J. C., Phelps, M. E., Pahl, J. J., Huang, S.-C., Baxter, L. R., Riege, W. H., Hoffman, J. M., Kuhl, D. E., Lanto, A. B., Wapenski, J. A., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702123160701 · Cited by 314
Isacson, O., Brundin, P., Kelly, P. A. T., Gage, F. H., & Björklund, A. (1984) · Nature · doi:10.1038/311458a0 · Cited by 299
The role of specific ions in glutamate neurotoxicity
Olney, J. W., Price, M. T., Samson, L., & Labruyere, J. (1986) · Neuroscience Letters · doi:10.1016/0304-3940(86)90121-7 · Cited by 297
Neurons Containing NADPH-Diaphorase Are Selectively Resistant to Quinolinate Toxicity
Koh, J.-Y., Peters, S., & Choi, D. W. (1986) · Science · doi:10.1126/science.2875522 · Cited by 287
Dementia of the Alzheimer's Type: Changes in Hippocampal L‐[3H]Glutamate Binding
Greenamyre, J. T., Penney, J. B., D'Amato, C. J., & Young, A. B. (1987) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1987.tb04127.x · Cited by 279
Haxby, J. V., Grady, C. L., Duara, R., Schlageter, N., Berg, G., & Rapoport, S. I. (1986) · Archives of Neurology · doi:10.1001/archneur.1986.00520090022010 · Cited by 270
Regional Mitochondrial Respiratory Activity in Huntington's Disease Brain
Brennan, W. A., Bird, E. D., & Aprille, J. R. (1985) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1985.tb07192.x · Cited by 264
Yates, C. M., Butterworth, J., Tennant, M. C., & Gordon, A. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb04948.x · Cited by 263
Swartz, K., During, M., Freese, A., & Beal, M. (1990) · The Journal of Neuroscience · doi:10.1523/jneurosci.10-09-02965.1990 · Cited by 258
Self-citationSparing of acetylcholinesterase-containing striatal neurons in Huntington's disease
Ferrante, R. J., Flint Beal, M., Kowall, N. W., Richardson, E. P., & Martin, J. B. (1987) · Brain Research · doi:10.1016/0006-8993(87)90694-9 · Cited by 257
Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington's disease
Dawbarn, D., De Quidt, M. E., & Emson, P. C. (1985) · Brain Research · doi:10.1016/0006-8993(85)90921-7 · Cited by 251
Albin, R. L., Young, A. B., Penney, J. B., Handelin, B., Balfour, R., Anderson, K. D., Markel, D. S., Tourtellotte, W. W., & Reiner, A. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005033221807 · Cited by 243
Rapid ATP Loss Caused by 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine in Mouse Brain
Chan, P., DeLanney, L. E., Irwin, I., Langston, J. W., & Di Monte, D. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb02134.x · Cited by 241
Howell, N., Kubacka, I., Xu, M., & McCullough, D. A. (1991) · PubMed · Cited by 237
Graft-induced behavioral recovery in an animal model of Huntington disease.
Isacson, O., Dunnett, S. B., & Björklund, A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.8.2728 · Cited by 235
Hamilton, B. F., & Gould, D. H. (1987) · Acta Neuropathologica · doi:10.1007/bf00691103 · Cited by 230
Evidence for a defect in NADH: ubiquinone oxidoreductase (complex I) in Huntington's disease
Parker, W. D., Boyson, S. J., Luder, A. S., & Parks, J. K. (1990) · Neurology · doi:10.1212/wnl.40.8.1231 · Cited by 230
Abnormal Glutamate Metabolism in an Adult-Onset Degenerative Neurological Disorder
Plaitakis, A., Berl, S., & Yahr, M. D. (1982) · Science · doi:10.1126/science.6121377 · Cited by 225
Rat Brain Slices Produce and Liberate Kynurenic Acid upon Exposure to l‐Kynurenine
Turski, W. A., Gramsbergen, J. B. P., Traitler, H., & Schwarcz, R. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09218.x · Cited by 218
CORTICAL AND SUBCORTICAL GLUCOSE CONSUMPTION MEASURED BY PET IN PATIENTS WITH HUNTINGTON'S DISEASE
KUWERT, T., LANGE, H. W., LANGEN, K.-J., HERZOG, H., AULICH, A., & FEINENDEGEN, L. E. (1990) · Brain · doi:10.1093/brain/113.5.1405 · Cited by 217
Uemura, Y., Kowall, N. W., & Beal, M. F. (1990) · Annals of Neurology · doi:10.1002/ana.410270606 · Cited by 216
Self-citationPlaitakis, A., Constantakakis, E., & Smith, J. (1988) · Annals of Neurology · doi:10.1002/ana.410240314 · Cited by 209
Ramsay, R. R., Krueger, M. J., Youngster, S. K., Gluck, M. R., Casida, J. E., & Singer, T. P. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb11409.x · Cited by 209
Koek, W., & Colpaert, F. C. (1990) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13353-3 · Cited by 203
Neckelmann, N., Li, K., Wade, R. P., Shuster, R., & Wallace, D. C. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7580 · Cited by 201
Mechanism of the neurotoxicity of MPTP: An update
(1990) · FEBS Letters · doi:10.1016/0014-5793(90)81315-f · Cited by 199
Beal, M. F., Kowall, N. W., Swartz, K. J., Ferrante, R. J., & Martin, J. B. (1989) · Synapse · doi:10.1002/syn.890030106 · Cited by 193
Self-citationOzawa, T., Tanaka, M., Ikebe, S.-I., Ohno, K., Kondo, T., & Mizuno, Y. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)90698-m · Cited by 187
Herkenham, M., Little, M. D., Bankiewicz, K., Yang, S.-C., Markey, S. P., & Johannessen, J. N. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90180-v · Cited by 180
Wallace Dickel, A., Robinson, R. G., Coyle, J. T., & Sanberg, P. R. (1983) · European Journal of Pharmacology · doi:10.1016/0014-2999(83)90150-4 · Cited by 180
KUHN-NENTWIG, L., & KADENBACH, B. (1985) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1985.tb08905.x · Cited by 176
Hantraye, P., Riche, D., Maziere, M., & Isacson, O. (1990) · Experimental Neurology · doi:10.1016/0014-4886(90)90014-j · Cited by 175
Lowered cerebral glucose utilization in amyotrophic lateral sclerosis
Dalakas, M. C., Hatazawa, J., Brooks, R. A., & Di Chiro, G. (1987) · Annals of Neurology · doi:10.1002/ana.410220504 · Cited by 168
Joyce, J. N., & Marshall, J. F. (1987) · Neuroscience · doi:10.1016/0306-4522(87)90240-5 · Cited by 167
Amyotrophic lateral sclerosis: Amino acid levels in plasma and cerebrospinal fluid
Perry, T. L., Krieger, C., Hansen, S., & Eisen, A. (1990) · Annals of Neurology · doi:10.1002/ana.410280105 · Cited by 163
Zeevalk, G. D., & Nicklas, W. J. (1990) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13234-5 · Cited by 163
Mechanisms underlying initiation of excitotoxicity associated with metabolic inhibition.
Zeevalk, G. D., & Nicklas, W. J. (1991) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24721-8 · Cited by 163
Ihara, Y., Namba, R., Kuroda, S., Sato, T., & Shirabe, T. (1989) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(89)90112-3 · Cited by 161
The MPTP model: versatile contributions to the treatment of idiopathic Parkinson's disease
Bloem, B. R., Irwin, I., Buruma, O. J. S., Haan, J., Roos, R. A. C., Tetrud, J. W., & Langston, J. W. (1990) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(90)90225-c · Cited by 160
The quinolinic acid model of Huntington's disease: Locomotor abnormalities
Sanberg, P. R., Calderon, S. F., Giordano, M., Tew, J. M., & Norman, A. B. (1989) · Experimental Neurology · doi:10.1016/0014-4886(89)90170-2 · Cited by 159
Positron emission tomography in the early diagnosis of Huntington's disease
Hayden, M. R., Martin, W. R. W., Stoessl, A. J., Clark, C., Hollenberg, S., Adam, M. J., Ammann, W., Harrop, R., Rogers, J., Ruth, T., et al. (1986) · Neurology · doi:10.1212/wnl.36.7.888 · Cited by 159
Palaiologos, G., Hertz, L., & Schousboe, A. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb04872.x · Cited by 158
Selective sparing of NADPH‐diaphorase neurons in neonatal hypoxia‐ischemia
Ferriero, D. M., Arcavi, L., Sagar, S. M., McIntosh, T. K., & Simon, R. P. (1988) · Annals of Neurology · doi:10.1002/ana.410240512 · Cited by 152
Butterworth, J., Yates, C. M., & Reynolds, G. P. (1985) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(85)90112-1 · Cited by 150
Novotny, E. J., Singh, G., Wallace, D. C., Dorfman, L. J., Louis, A. A., Sogg, R. L., & Steinman, L. (1986) · Neurology · doi:10.1212/wnl.36.8.1053 · Cited by 150
Mitochondrial function and parental sex effect in Huntington's disease
Mann, V. M. (1990) · The Lancet · doi:10.1016/0140-6736(90)92242-a · Cited by 147
DiMauro, S., Bonilla, E., Lee, C. P., Schotland, D. L., Scarpa, A., Conn, H. L., & Chance, B. (1976) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(76)90063-0 · Cited by 140
Cyanide‐induced parkinsonism: A clinicopathologic report
Uitti, R. J., Rajput, A. H., Ashenhurst, E. M., & Rozdilsky, B. (1985) · Neurology · doi:10.1212/wnl.35.6.921 · Cited by 135
Koh, J., & Choi, D. W. (1988) · Brain Research · doi:10.1016/0006-8993(88)90897-9 · Cited by 131
Two distinct genes for ADP/ATP translocase are expressed at the mRNA level in adult human liver.
Houldsworth, J., & Attardi, G. M. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.2.377 · Cited by 126
Davies, S. W., & Roberts, P. J. J. (1987) · Nature · doi:10.1038/327326a0 · Cited by 124
Cyanide‐induced parkinsonism: Clinical, MRI, and 6‐fluorodopa PET studies
Rosenberg, N. L., Myers, J. A., & Martin, W. R. W. (1989) · Neurology · doi:10.1212/wnl.39.1.142 · Cited by 123
Brain glutamate deficiency in amyotrophic lateral sclerosis
Perry, T. L., Hansen, S., & Jones, K. L. (1987) · Neurology · doi:10.1212/wnl.37.12.1845 · Cited by 121
Gould, D. H., & Gustine, D. L. (1982) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1982.tb00306.x · Cited by 118
Aminooxyacetic Acid Results in Excitotoxin Lesions by a Novel Indirect Mechanism
Beal, M. F., Swartz, K. J., Hyman, B. T., Storey, E., Finn, S. F., & Koroshetz, W. J. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb08258.x · Cited by 118
Self-citationFitzpatrick, S. M., Cooper, A. J. L., & Duffy, T. E. (1983) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1983.tb00835.x · Cited by 113
Parker, W. D., Oley, C. A., & Parks, J. K. (1989) · New England Journal of Medicine · doi:10.1056/nejm198905183202007 · Cited by 113
Cortical Motor-Sensory Hypometabolism in Amyotrophic Lateral Sclerosis
Hatazawa, J., Brooks, R., Dalakas, M. C., Mansi, L., & Chiro, G. D. (1988) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-198807000-00019 · Cited by 112
Sequence of metabolic, clinical, and histological events in experimental thiamine deficiency
Hakim, A. M., & Pappius, H. M. (1983) · Annals of Neurology · doi:10.1002/ana.410130403 · Cited by 111
Grafton, S. T., Mazziotta, J. C., Pahl, J. J., George‐Hyslop, P. S., Haines, J. L., Gusella, J. F., Hoffman, J. M., Baxter, L. R., & Phelps, M. E. (1990) · Annals of Neurology · doi:10.1002/ana.410280503 · Cited by 110
Kauppinen, R. A., Sihra, T. S., & Nicholls, D. G. (1987) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(87)90029-2 · Cited by 110
Ubidecarenone in the treatment of mitochondrial myopathies: a multi-center double-blind trial
Bresolin, N., Doriguzzi, C., Ponzetto, C., Angelini, C. I., Moroni, I., Castelli, E., Cossutta, E., Binda, A., Gallanti, A., Gabellini, S., et al. (1990) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(90)90015-f · Cited by 108
Hayden, M. R., Hewitt, J., Stoessl, A. J., Clark, C., Ammann, W., & Martin, W. R. W. (1987) · Neurology · doi:10.1212/wnl.37.9.1441 · Cited by 107
Chesselet, M., Gonzales, C., Lin, C.-S., Polsky, K., & Jin, B.-K. (1990) · Experimental Neurology · doi:10.1016/0014-4886(90)90032-n · Cited by 106
Lombès, A., Mendell, J. R., Nakase, H., Barohn, R. J., Bonilla, E., Zeviani, M., Yates, A. J., Omerza, J., Gales, T. L., Nakahara, K., et al. (1989) · Annals of Neurology · doi:10.1002/ana.410260104 · Cited by 106
Chiamulera, C., Costa, S., & Reggiani, A. M. (1990) · Psychopharmacology · doi:10.1007/bf02247140 · Cited by 103
Therapy of mitochondrial disorders
Przyrembel, H. (1987) · Journal of Inherited Metabolic Disease · doi:10.1007/bf01812853 · Cited by 102
Nishikawa, Y., Takahashi, M. M., Yorifuji, S., Nakamura, Y., Ueno, S., Tarui, S., Kozuka, T., & Nishimura, T. (1989) · Neurology · doi:10.1212/wnl.39.3.399 · Cited by 100
EXPERIMENTAL DEMYELINATION OF THE CENTRAL NERVOUS SYSTEM
Hurst, E. W. (1942) · Immunology and Cell Biology · doi:10.1038/icb.1942.48 · Cited by 100
Quinolinic acid does not spare striatal neuropeptide Y-immunoreactive neurons
Boegman, R. J., Smith, Y., & Parent, A. (1987) · Brain Research · doi:10.1016/0006-8993(87)90284-8 · Cited by 98
Selman, W. R., Spetzler, R. F., Roessmann, U., Rosenblatt, J. I., & Crumrine, R. C. (1981) · Journal of neurosurgery · doi:10.3171/jns.1981.55.2.0220 · Cited by 97
Potassium channel activators abolish excitotoxicity in cultured hippocampal pyramidal neurons
Abele, A. E., & Miller, R. J. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90454-h · Cited by 93
Influence of the Malate‐Aspartate Shuttle on Oxidative Metabolism in Synaptosomes
Cheeseman, A. J., & Clark, J. B. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb03044.x · Cited by 91
Sanberg, P. R., Lehmann, J. C., & Fibiger, H. C. (1978) · Brain Research · doi:10.1016/0006-8993(78)90502-4 · Cited by 90
Deficiency of subunits of complex I and mitochondrial encephalomyopathy
Ichiki, T., Tanaka, M., Nishikimi, M., Suzuki, H., Ozawa, T., Kobayashi, M., & Wada, Y. (1988) · Annals of Neurology · doi:10.1002/ana.410230312 · Cited by 90
Normal Caudate Glucose Metabolism in Persons at Risk for Huntington's Disease
Young, A. B., Penney, J. B., Starosta‐Rubinstein, S., Markel, D. S., Berent, S., Rothley, J., Betley, A. T., & Hichwa, R. D. (1987) · Archives of Neurology · doi:10.1001/archneur.1987.00520150010010 · Cited by 88
Isoforms of Mammalian Cytochrome c Oxidase:Correlation with Human Cytochrome c Oxidase Deficiency
Keenaway, N. G., Carrero-Valenzuela, R. D., Ewart, G. W., Balan, V. K., Lightowlers, R. N., Zhang, Y., Powell, B. R., Capaldi, R., & Buist, N. R. M. (1990) · Pediatric Research · doi:10.1203/00006450-199011000-00024 · Cited by 82
Kowall, N. W., & Beal, M. F. (1991) · Annals of Neurology · doi:10.1002/ana.410290208 · Cited by 80
Self-citationEnergy metabolism in disorders of the nervous system.
Blass, J. P., Sheu, R., & Cedarbaum, J. M. (1988) · PubMed · Cited by 78
Waldvogel, H. J., Faull, R. L. M., Williams, M. N., & Dragunow, M. (1991) · Brain Research · doi:10.1016/0006-8993(91)91497-o · Cited by 76
Zheng, X., Shoffner, J. M., Lott, M. T., Voljavec, A. S., Krawiecki, N., Winn, K. J., & Wallace, B. C. (1989) · Neurology · doi:10.1212/wnl.39.9.1203 · Cited by 75
Molecular defects of NADH-ubiquinone oxidoreductase (Complex I) in mitochondrial diseases
MORGAN-HUGHES, J. A., Schapira, A. H. V., Cooper, J. A. D., & Clark, J. B. (1988) · Journal of Bioenergetics and Biomembranes · doi:10.1007/bf00769638 · Cited by 71
LoTurco, J. J., Módy, I., & Kriegstein, A. R. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90574-s · Cited by 69
Neurological disease and mitochondrial genes
Harding, A. E. (1991) · Trends in Neurosciences · doi:10.1016/0166-2236(91)90081-5 · Cited by 66
Aminooxyacetic acid produces excitotoxic lesions in the rat striatum
Urbańska, E. M., Ikonomidou, C., Sieklucka, M., & Turski, W. A. (1991) · Synapse · doi:10.1002/syn.890090207 · Cited by 66
Schwarcz, R. M., Bennett, J. P., & Coyle, J. T. (1977) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1977.tb10641.x · Cited by 64
Movement disorders in mitochondrial myopathies. A study of nine cases with two autopsy studies
Truong, D. D., Harding, A. E., Scaravilli, F., Smith, S. J. M., MORGAN-HUGHES, J. A., & MARSDEN, C. D. (1990) · Movement Disorders · doi:10.1002/mds.870050204 · Cited by 62
Mitochondrial genes and disease.
Dc, W. (1986) · PubMed · Cited by 55
Mitochondrial DNA in Postmortem Brain from Patients with Parkinson's Disease
Lestienne, P. P., Nelson, I. P., Riederer, P. F., Reichmann, H., & Jellinger, K. A. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb02087.x · Cited by 50
McKelvie, P. A., Morley, J., Byrne, E., & Marzuki, S. (1991) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(91)90093-m · Cited by 50
Beal, M. F., Kowall, N. W., Swartz, K. J., & Ferrante, R. J. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90702-b · Cited by 41
Self-citationBernsen, P. L. J. A., Gabreëls, F. J. M., Ruitenbeek, W., Sengers, R. C. A., Stadhouders, A. M., & Renier, W. O. (1991) · Archives of Neurology · doi:10.1001/archneur.1991.00530150106028 · Cited by 41
Neuropathology of myoclonus epilepsy associated with ragged-red fibers (Fukuhara's disease)
Takeda, S., Wakabayashi, K., Ohama, E., et al. (1988) · Acta Neuropathologica · doi:10.1007/bf00687129 · Cited by 40
Matthews, P. M., Berkovic, S. F., Shoubridge, E. A., Andermann, F., Karpati, G., Carpenter, S., & Arnold, D. L. (1991) · Annals of Neurology · doi:10.1002/ana.410290416 · Cited by 33
Masuo, Y., Montagne, M., Pélaprat, D., et al. (1990) · Brain Research · doi:10.1016/0006-8993(90)91686-b · Cited by 28
Choreoathetosis and striopallidonigral necrosis due to sodium azide
Mettler, F. A. (1972) · Experimental Neurology · doi:10.1016/0014-4886(72)90175-6 · Cited by 25
Shew, R. L., Robinson, M. F., Olansky, L., Yee, J. A., Titishov, N., Mechoulam, R., Zimmerman, A. M., Raghoebar, M., Tiemessen, H. L. G. M., van den Berg, W. B., et al. (2008) · Pharmacology · doi:10.1159/000138630 · Cited by 18
MPTP-Induced Neurotoxicity and the Quest for a Preventative Therapy for Parkinson's Disease
Furtado, J., & Mazurek, M. F. (1991) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100031346 · Cited by 12
The role of mitochondrial DNA in Huntington's disease
Irwin, C. C., Wexler, N. S., Young, A. B., Ozelius, L. J., Penney, J. B., Shoulson, I., Snodgrass, S. R., Ramos-Arroyo, M. A., Sanchez‐Ramos, J., Penchaszadeh, G. K., et al. (1989) · Journal of Molecular Neuroscience · doi:10.1007/bf02918898 · Cited by 10
Cited by
Oxidative stress hypothesis in Alzheimer’s disease
Markesbery, W. R. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00629-6 · Cited by 2,383
Oxidative damage and mitochondrial decay in aging.
Shigenaga, M. K., Hagen, T. M., & Ames, B. N. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.10771 · Cited by 2,055
Glutamate as a neurotransmitter in the brain: review of physiology and pathology
Meldrum, B. S. (2000) · The Journal of Nutrition · doi:10.1093/jn/130.4.1007s · Cited by 1,667
Aging, energy, and oxidative stress in neurodegenerative diseases
Beal, M. F. (1995) · Annals of Neurology · doi:10.1002/ana.410380304 · Cited by 1,440
Self-citationETIOLOGY AND PATHOGENESIS OF PARKINSON'S DISEASE
Olanow, C. W., & Tatton, W. G. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.123 · Cited by 1,396
Metadata
- Authors
- Beal, M. F.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1992-02
- Volume
- 31
- Issue
- 2
- Pages
- 119-130
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2145213346
- Cited by
- 961
- References
- 147
- FWCI
- 21.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.